Kenya
Kenya, with a population of 31 million, has an estimated 1.25 million HIV-infected people, or a 7 percent seroprevalence rate. HIV accounts for more than half of all hospital admissions. Currently, an estimated 200,000 Kenyans need antiretroviral treatment (ART).
In 2003, ICAP, through a collaboration with Indiana University, began supporting the government of Kenya in its efforts to provide HIV/AIDS care and treatment at health facilities in the western region of the country. More recently, ICAP began supporting HIV/AIDS programming in the country’s Central Province.
Specific activities include:
- HIV/AIDS prevention, care, and treatment, including provision of antiretroviral therapy;
- Integrated tuberculosis/HIV care and treatment;
- Rapid HIV testing for adults and children;
- Diagnostic testing/analysis, including Dried Blood Spot DNA PCR testing for infants;
- Training programs for all cadres of healthcare providers of HIV/AIDS prevention, care, and treatment;
- Community outreach;
- HIV support groups, including medication and treatment adherence;
- Peer education programs;
- Social services/social support;
- Nutrition support;
- Referral services;
- Home-based/community-based visits;
- Development and implementation of patient-information systems;
- Pharmacy services;
- Laboratory support;
- Targeted evaluations.